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1. Introduction 
Recently Miller [ 1 ] has thrown some light on the 
effects of many carcinogenic chemicals. He has shown 
that the activity of these compounds or their meta- 
bolic derivatives is related to their strong electrophilic 
reactivity. The active form of those carcinogens is 
covalently bound to nucleic acids and proteins in 
induced tumors [ 11. 
In the case of acetylaminofluorene (AAF) Miller 
et al. [2] have shown that the last metabolic deri- 
vative was an ester of N-hydroxy-AAF. We have 
therefore studied the effects of N-acetoxy-AAF (N- 
AcO-AAF) on native DNA. The analysis of melting 
profiles of modified DNA gives evidence for a de- 
stabilizing effect which is interpreted as the opening 
of G-C base pairs. Furthermore it is likely that the 
carcinogen reacts preferentially with G-C rich regions. 
2. Material and methods 
Native calf-thymus DNA (V 371) with the following 
characteristics was used: protein content < 0.1%; 
hyperchromicity at 260 nm 42%;SZ0,w = 21 S; 
[q] = 6200 ml/g in 0.3 M ionic strength. 
N-AcO-AAF was synthesized as previously de- 
scribed [3]. The reaction of the carcinogen with 
DNA was performed according to Miller [4]. 
When the reaction was completed, the excess of 
fluorene derivative was extracted twice with ethylic 
ether. The free residues of fluorene and ethanol were 
removed by extensive dialysis against 2 X 10e3 M 
citrate buffer, pH 7.0. This solvent was used for all 
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the experiments. In some cases Sephadex G25 was 
used with the same results. 
The covalent fixation of N-AcO-AAF on guanine 
[4] caused a shift of the U.V. spectrum of DNA 
from 257 to 262 nm and the appearance of a shoul- 
der at 305 nm. The magnitude of these effects was 
related to the quantity of bound carcinogen. 
We have studied the progressive fixation of N- 
AcO-AFF with an initial ratio C/P (carcinogen/phos- 
phate) varying from 0 to 1.2. 
The system described by Wilhelm et al. [5] was 
used to follow the melting curves at 260 and 305 nm. 
This apparatus records directly absorbance versus 
temperature. 
3. Results and discussion 
The cooperative melting curves obtained at 305 nm 
(fig. 1) can only be explained if we assume that the 
Fig. 1. Melting curve at 305 nm of a modified DNA in which 
31% of total guanine have reacted with N-AcO-AAF (2 X 10e3 
M citrate buffer pH 7). Temperature is increasing linearly at 
a rate of 1 “C/min. 
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Fig. 2. Correlation between experimental points and curve 
calculated as described in the text. 
carcinogen chromophore is imbedded in the internal 
field of the double helix. We found that the optical 
properties of bound carcinogen are independent of 
C/P, provided that the amount of carcinogen is kept 
constant [6]. 
The hyperchromicity at 305 nm enables direct 
determination of the percentage of modified guanines. 
If we assume that the specific extinction coefficient 
of the carcinogen is the same when bound to guano- 
sine [7] or to denatured DNA, we can calculate the 
amount of modified guanines [6]. 
If the carcinogen hyperchromicity is independent 
of wavelength in the range 260-305 nm, the carci- 
nogen contribution can be subtracted from the ex- 
perimental melting curve in order to calculate DNA 
hyperchromicity (fig. 2). 
A simple way to interpret the data is to assume 
that the decrease of hyperchromicity is caused by a 
rupture of hydrogen bonds between G and C. One 
would expect a linear variation of hyperchromicity 
with the amount of bound carcinogen; as shown in 
fig. 2, experimental points fit well with this predicted 
relationship. 
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Fig. 3. Variation of T,,, at two wavelengths (305 nm and 260 
nm) versus amount of modified guanines. 
Fig. 3 shows that T, for both wavelengths (260 
nm and 305 nm) decreases linearly with the amount 
of modified guanine. T, at 260 nm (Tzm ) was 
always lower than T, at 305 nm (Tzq. The first 
observation indicates a strong destabilisation of mo- 
dified DNA. The extrapolation of the curves Tim 
to 100% of reacted guanines gives T,,, of DNA con- 
sisting only of A-T pairs. The value found (38”) 
is comparable to the melting temperature of poly 
dA-dT in the same conditions [8]. 
The systematic higher value of TF compared 
to Tkm may be explained in two ways: 
a) The intercalation of carcinogen aromatic ring 
between base plates and the strong interaction with 
those bases would increase the local stability in 
DNA. Therefore the melting temperature of this 
region should be higher. But this hypothesis is hard- 
ly compatible with the fact that TG’ decreases as 
the amount of modified guanines increases. 
b) The carcinogen reacts preferentially with regions 
of high G-C content. Even if the modification of 
guanine destabilizes the base pair involved, the car- 
cinogen environment may have a higher melting tem- 
perature than the other parts of the DNA molecule. 
As the amount of bound carcinogen increases, 
the difference between TF and Tkpo must decrease 
since any heterogeneity in the DNA tends to disappear. 
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We are now developing new analytical methods References 
to test this last assumption, which so far represents 
a more convenient explanation of the experimental 
facts. It offers, moreover, a new insight into the bio- 
logical mechanism of carcinogenesis. 
111 
[21 
[31 
[41 
Acknowledgements 
151 
This research was supported by a grant of the 
Ligue Nationale Franqaise contre le Cancer. It is a 
pleasure to thank Dr. Biellmann for providing labo- 
ratory facilities to synthesize the carcinogen. 
161 
(71 
181 
May 1971 
J.A. Miller, Cancer Res. 30 (1970) 559. 
J.A. Miller and E.C. Miller, Prog. Exptl. Tumor Res. 11 
(1969) 273. 
P.D. Lotlikar, J.D. Scribner, J.A. Miller and E.C. Miller, 
Life Sci. 5 (1966) 1263. 
E.C. Miller, U. Juhl and J.A. Miller, Science 153 (1966) 
1125. 
F.X. Wilhelm, M.H. Champagne and M.P. Daune, European 
J. Biochem. 15 (1970) 321. 
R. Fuchs and M. Daune, manuscript in preparation. 
E. Kriek, J.A. Miller, U. Juhl and E.C. Miller, Biochemistry 
6 (1967) 177. 
M. Riley, B. Maling and M.J. Chamberlin, J. Mol. Biol. 20 
(1966) 359. 
208 
